These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 35601487)

  • 1. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Huang H; Zhou W; Chen R; Xiang B; Zhou S; Lan L
    Front Mol Biosci; 2021; 8():611508. PubMed ID: 33681290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma.
    Liu Q; Li R; Wu H; Liang Z
    BMC Cancer; 2023 Mar; 23(1):226. PubMed ID: 36894917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
    Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
    Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.
    Liu K; Li L; Han G
    Front Endocrinol (Lausanne); 2023; 14():1226547. PubMed ID: 38333724
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway.
    Li M; Han Y; Zhou H; Li X; Lin C; Zhang E; Chi X; Hu J; Xu H
    Cell Death Dis; 2018 Jan; 9(2):91. PubMed ID: 29367600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma.
    Wu X; Hao L; Lin J; Guo X; Luo Y; Li C
    Front Immunol; 2024; 15():1399222. PubMed ID: 39026679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses.
    Li TH; Qin XH; Wang LQ; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Heliyon; 2023 Oct; 9(10):e20464. PubMed ID: 37842592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of epithelial splicing regulatory protein 1 (ESRP1) associated with tumor immunity in pancreatic adenocarcinoma.
    Wang P; Gao X; Zheng W; Zhang J
    J Proteomics; 2024 Sep; 308():105277. PubMed ID: 39127164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy.
    Shi Y; Wang Y; Dong H; Niu K; Zhang W; Feng K; Yang R; Zhang Y
    Apoptosis; 2023 Oct; 28(9-10):1423-1435. PubMed ID: 37369808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
    Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
    BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value and the Immune Microenvironment-associated Role of
    Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
    Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-related genes prognostic signature for pancreatic cancer and immune infiltration: potential biomarkers for predicting overall survival.
    Wang L; Wu Z; Xu C; Ye H
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18119-18134. PubMed ID: 38007403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zheng Q; Xie Y; Xu L; Chen D; Wu J; Liu S; Wu L; Fang P; Xie F
    J Gastrointest Oncol; 2024 Aug; 15(4):1746-1759. PubMed ID: 39279982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.